-
Benchmark Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND)
Источник: Buzz FX / 23 дек 2024 08:36:12 America/Chicago
Benchmark Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND) Written by MarketBeat December 23, 2024 Share Link copied to clipboard. Ligand Pharmaceuticals ( NASDAQ:LGND - Get Free Report ) 's stock had its "buy" rating restated
Read more...